John Cabatu
About John Cabatu
John Cabatu is the Associate Director of CMC-QA Product Development Quality at Bristol Myers Squibb, with extensive experience in quality management and compliance in the pharmaceutical industry.
Company
John Cabatu is currently working as the Associate Director, CMC-QA Product Development Quality at Bristol Myers Squibb, a prominent global biopharmaceutical company. Bristol Myers Squibb is known for discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases.
Title
As the Associate Director, CMC-QA Product Development Quality, John Cabatu is responsible for ensuring that the Quality Management Systems (QMS) for cell banks, raw materials, and component releases are effectively managed. His role requires a high level of collaboration with Operations, Analytical, and other support groups to maintain GxP compliance.
Previous Experience at Merck
Prior to his current role, John Cabatu served as the Associate Director, Clinical Supplies at Merck from 2020 to 2022. During his tenure at Merck in Rahway, New Jersey, he was involved in managing clinical supplies effectively to support global clinical trials.
Previous Roles at Bristol-Myers Squibb
John Cabatu has a long history with Bristol Myers Squibb, having held various roles over the years. From 2015 to 2020, he worked as a Product Disposition Manager at the Hopewell site in Pennington, NJ. Before that, he was a QA Specialist in Biologics Development Quality Operations (BDQO) from 2010 to 2015, focusing on biologics quality assurance.
Education and Certifications
John Cabatu holds a Bachelor of Arts degree from Rutgers University. He has multiple certifications, including Quality Lead Coordinator (QLC) for Deviation/Investigation, Hazmat Shipper, and Certified Lift Truck Operator. These credentials highlight his commitment to continuous improvement and professional development in quality assurance.